APP and early-onset autosomal dominant Alzheimer disease: The study also shows that CERTL binds to Amyloid Precursor Protein (APP), influencing Aβ aggregation, neurotoxicity, and ceramide levels, opening new research avenues for Alzheimer’s disease and other neurodegenerative disorders.